GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CanBas Co Ltd (TSE:4575) » Definitions » EV-to-Revenue
中文

CanBas Co (TSE:4575) EV-to-Revenue : (As of Apr. 25, 2024)


View and export this data going back to 2009. Start your Free Trial

What is CanBas Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CanBas Co's enterprise value is 円6,600.72 Mil. CanBas Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円0.00 Mil. Therefore, CanBas Co's EV-to-Revenue for today is .

The historical rank and industry rank for CanBas Co's EV-to-Revenue or its related term are showing as below:

During the past 13 years, the highest EV-to-Revenue of CanBas Co was 901.69. The lowest was 15.78. And the median was 35.15.

TSE:4575's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.63
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), CanBas Co's stock price is 円456.00. CanBas Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円0.00. Therefore, CanBas Co's PS Ratio for today is .


CanBas Co EV-to-Revenue Historical Data

The historical data trend for CanBas Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanBas Co EV-to-Revenue Chart

CanBas Co Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.64 44.23 28.45 - -

CanBas Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CanBas Co's EV-to-Revenue

For the Biotechnology subindustry, CanBas Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanBas Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CanBas Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CanBas Co's EV-to-Revenue falls into.



CanBas Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CanBas Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6600.719/0
=

CanBas Co's current Enterprise Value is 円6,600.72 Mil.
CanBas Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanBas Co  (TSE:4575) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CanBas Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=456.00/0
=

CanBas Co's share price for today is 円456.00.
CanBas Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanBas Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CanBas Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CanBas Co (TSE:4575) Business Description

Traded in Other Exchanges
N/A
Address
9 Toriyoko-cho, Shizuoka, JPN, 410-0891
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.

CanBas Co (TSE:4575) Headlines

No Headlines